Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
EV/EBIT
35.96 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Teva Pharmaceutical Industries Ltd's enterprise value is $59,301 Mil. Teva Pharmaceutical Industries Ltd's operating income for the trailing twelve months (TTM) ended in Dec. 2013 was $1,649 Mil. Therefore, Teva Pharmaceutical Industries Ltd's EV/EBIT ratio for today is 35.96.

TEVA' s 10-Year EV/EBIT Range
Min: 11.7   Max: 990.4
Current: 35.96

11.7
990.4

During the past 13 years, the highest EV/EBIT Ratio of Teva Pharmaceutical Industries Ltd was 990.40. The lowest was 11.70. And the median was 20.70.

TEVA's EV/EBITis ranked lower than
56% of the 593 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 19.45 vs. TEVA: 35.96 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Teva Pharmaceutical Industries Ltd's enterprise value for the quarter that ended in Dec. 2013 was $45,092 Mil. Teva Pharmaceutical Industries Ltd's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was $1,649 Mil. Teva Pharmaceutical Industries Ltd's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 was 3.66%.


Definition

Teva Pharmaceutical Industries Ltd's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=59301.244/1649
=35.96

Teva Pharmaceutical Industries Ltd's current Enterprise Value is $59,301 Mil.
Teva Pharmaceutical Industries Ltd's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was 874 (Mar. 2013 ) + -586 (Jun. 2013 ) + 801 (Sep. 2013 ) + 560 (Dec. 2013 ) = $1,649 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Teva Pharmaceutical Industries Ltd's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2013 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Dec. 2013 )=Operating Income (TTM)/Enterprise Value (Q: Dec. 2013 )
=1649/45091.6
=3.66 %

Teva Pharmaceutical Industries Ltd's Enterprise Value for the quarter that ended in Dec. 2013 was $45,092 Mil.
Teva Pharmaceutical Industries Ltd's Operating Income for the trailing twelve months (TTM) ended in Dec. 2013 was 874 (Mar. 2013 ) + -586 (Jun. 2013 ) + 801 (Sep. 2013 ) + 560 (Dec. 2013 ) = $1,649 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebit 34.1921.1437.8215.8138.8022.1013.5515.8319.9227.34

Teva Pharmaceutical Industries Ltd Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
ev2ebit 12.2415.8316.6713.1919.4919.9221.0079.6330.6227.34
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide